118895290	118895290	CD	B-NP	O
|	|	NN	I-NP	O
LHMC	LHMC	NN	I-NP	O
|	|	NN	I-NP	O
14982405	14982405	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3240040	3240040	CD	B-NP	O
|	|	CC	I-NP	O
3/21/2004	3/21/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
malignant	malignant	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/21/2004	3/21/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/1/2004	7/1/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DISCIPIO	DISCIPIO	NNP	B-NP	O
,	,	,	O	O
DALLAS	DALLAS	NNP	B-NP	O
521-73-68-3	521-73-68-3	CD	I-NP	O
Si	Si	NNP	I-NP	O
Peakeanleighcho	Peakeanleighcho	NNP	I-NP	O
Tolenano	Tolenano	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/17/04	10/17/04	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
ride	ride	NN	I-NP	O
home	home	NN	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GAVALDON	GAVALDON	NN	B-NP	O
,	,	,	O	O
MICKEY	MICKEY	NNP	B-NP	O
RALPH	RALPH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
January	January	NNP	I-NP	O
AQUAPHOR	AQUAPHOR	NNP	I-NP	O
TOPICAL	TOPICAL	NNP	I-NP	O
TP	TP	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
patches	patch	NNS	I-NP	O
on	on	IN	B-PP	O
arms	arm	NNS	B-NP	O
,	,	,	O	O
hands	hand	VBZ	B-VP	O
LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
November	November	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	B-NP	O
=	=	SYM	B-VP	O
120	120	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/1/04	9/1/04	CD	B-NP	O
by	by	IN	B-PP	O
MCCRUM	MCCRUM	NNP	B-NP	O
,	,	,	O	O
GIL	GIL	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
wil	wil	NN	B-NP	O
monitor	monitor	NN	I-NP	O
SARNA	SARNA	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
QD	QD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
hands	hand	NNS	B-NP	O
,	,	,	O	O
arms	arm	NNS	B-NP	O
.	.	.	O	O

IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONIT	MONONIT	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
XL	XL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
November	November	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

150	150	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
November	November	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ATORVASTATIN	ATORVASTATIN	NN	B-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
40mg	40mg	CD	B-NP	O
pill	pill	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
,	,	,	O	O
CRESTT	CRESTT	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lane	Lane	NNP	I-NP	O
Koyama	Koyama	NNP	I-NP	O
,	,	,	O	O
9am	9am	CD	B-NP	O
6/2/04	6/2/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dwain	Dwain	NNP	I-NP	O
Hoofard	Hoofard	NNP	I-NP	O
,	,	,	O	O
cardiology	cardiology	NN	B-NP	O
,	,	,	O	O
SH	SH	NN	B-NP	O
,	,	,	O	O
February	February	NNP	B-NP	O
,	,	,	O	O
9.30	9.30	CD	B-NP	O
am	am	NN	I-NP	O
10/19/04	10/19/04	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
nurse	nurse	NN	I-NP	O
practitioner	practitioner	NN	I-NP	O
,	,	,	O	O
Craig	Craig	NNP	B-NP	O
Duford	Duford	NNP	I-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
9am	9am	CD	B-NP	O
7/15/04	7/15/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
malignant	malignant	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
chf	chf	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
malignant	malignant	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
medication	medication	NN	I-NP	O
non-compliance	non-compliance	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
noncompliance	noncompliance	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
stress	stress	NN	I-NP	O
mibi	mibi	AFX	O	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
6minute	6minute	CD	I-NP	O
stress	stress	NN	I-NP	O
,	,	,	O	O
lvef	lvef	NN	B-NP	O
38	38	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
inferior/inferolateral	inferior/inferolateral	JJ	I-NP	O
walls	wall	NNS	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
reversibility	reversibility	NN	I-NP	O
.	.	.	O	O

echo	echo	AFX	O	O
-	-	HYPH	O	O
>	>	SYM	O	O
EF20	EF20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	B-protein
HK	HK	NN	I-NP	I-protein
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
regional	regional	JJ	I-NP	O
variation	variation	NN	I-NP	O
,	,	,	O	O
enlarged	enlarge	VBD	B-VP	O
RV	RV	NN	B-NP	O
with	with	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
LA	LA	NN	I-NP	O
and	and	CC	I-NP	O
RA	RA	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
thickening	thickening	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
TV	TV	NN	I-NP	O
with	with	IN	B-PP	O
mod	mod	NN	B-NP	O
regurg	regurg	NN	I-NP	O
.	.	.	O	O

PA	PA	NN	B-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
54	54	CD	I-NP	O
mm	mm	NN	I-NP	O
HG	HG	NN	I-NP	O
.	.	.	O	O

-LSB-	-LSB-	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
EF	EF	NN	I-NP	O
58	58	CD	B-NP	O
%	%	NN	I-NP	O
-RSB-	-RSB-	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
56M	56M	NN	B-NP	O
p/w	p/w	NN	I-NP	O
decompensated	decompensate	VBD	B-VP	O
CHF	CHF	NN	B-NP	B-protein
from	from	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
CM	CM	NN	I-NP	I-protein
h/o	h/o	NN	I-NP	I-protein
cad	cad	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
mi	mi	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Dm2	Dm2	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
glaucoma	glaucoma	NN	B-NP	O
,	,	,	O	O
cognitive	cognitive	JJ	B-NP	O
impairment	impairment	NN	I-NP	O
.	.	.	O	O

Not	Not	RB	B-ADJP	O
adherent	adherent	JJ	I-ADJP	O
with	with	IN	B-PP	O
medication	medication	NN	B-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
included	include	VBD	B-VP	O
Norvasc	Norvasc	NNP	B-NP	O
10QD	10QD	NNP	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NNP	B-NP	O
25	25	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
micronase	micronase	NN	B-NP	O
5	5	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
,	,	,	O	O
timoptic	timoptic	JJ	B-NP	O
gtt	gtt	NN	I-NP	O
0.5	0.5	CD	I-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
MD	MD	NN	I-NP	O
visit	visit	NN	I-NP	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Nickolas	Nickolas	NNP	I-NP	O
Sgambati	Sgambati	NNP	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

Presented	Present	VBN	B-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
with	with	IN	B-PP	O
CC	CC	NN	B-NP	O
:	:	:	O	O
testicular	testicular	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
increased	increase	VBD	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Eats	Eat	NNS	B-NP	O
salty	salty	NN	I-NP	O
food	food	NN	I-NP	O
regularly	regularly	RB	B-ADVP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
adds	add	VBZ	B-VP	O
salt	salt	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
fevers/chills/night	fevers/chills/night	NN	I-NP	O
sweats	sweat	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
n/v/diarrhea	n/v/diarrhea	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ab	ab	NN	I-NP	O
pain/urine	pain/urine	NN	I-NP	O
discoloration/melena/brbpr	discoloration/melena/brbpr	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	JJ	B-NP	B-cell_line
T95.P113	T95.P113	NN	I-NP	I-cell_line
,	,	,	O	O
BP215/123	BP215/123	NN	B-NP	B-protein
,	,	,	O	O
SaO2	SaO2	NN	B-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
grossly	grossly	RB	B-NP	O
vol	vol	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

given	give	VBN	B-PP	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
for	for	IN	B-PP	O
ekg	ekg	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
iv	iv	NN	I-NP	O
,	,	,	O	O
NTG	NTG	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

Diuresed	Diurese	VBN	B-NP	O
1400cc	1400cc	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
12B	12B	NN	B-NP	B-DNA
T97	T97	NN	I-NP	I-DNA
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
190/100	190/100	CD	I-NP	I-DNA
,	,	,	O	O
P88	P88	NN	B-NP	B-protein
,	,	,	O	O
RR18	RR18	NN	B-NP	B-protein
,	,	,	O	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
aaox3	aaox3	NN	I-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	O
tragus	tragus	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
pmi	pmi	NN	B-NP	O
lateral/diffuse	lateral/diffuse	RB	B-ADVP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S4	S4	NN	B-NP	B-protein
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
;	;	:	O	O
lungs	lung	VBZ	B-VP	O
bibasilar	bibasilar	JJ	B-NP	O
faint	faint	JJ	I-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
ab	ab	NN	B-NP	O
distended	distend	VBN	B-VP	O
,	,	,	O	O
nt	nt	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hsmg	hsmg	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
BS	BS	NNP	B-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
rebound/guarding	rebound/guarding	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
+	+	SYM	O	O
+	+	SYM	O	O
scrotal/penile	scrotal/penile	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
thighs	thigh	NNS	B-NP	O
.	.	.	O	O

multiple	multiple	JJ	B-NP	O
excoriations	excoriation	NNS	I-NP	O
,	,	,	O	O
eczema	eczema	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
fingers	finger	NNS	B-NP	O
.	.	.	O	O

ekg	ekg	LS	B-LST	O
:	:	:	O	O
lvh	lvh	NN	B-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
,	,	,	O	O
rrr	rrr	NN	B-NP	B-protein
,	,	,	O	O
stdep	stdep	NN	B-NP	O
V1	V1	NN	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

old	old	JJ	B-NP	O
q	q	NN	I-NP	O
im	im	NN	I-NP	O
III	III	CD	I-NP	O
.	.	.	O	O

cxr	cxr	NN	B-NP	O
:	:	:	O	O
cardio	cardio	NN	B-NP	O
,	,	,	O	O
megaly	megaly	RB	B-ADVP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

***	***	SYM	O	O
Assessment	Assessment	NN	B-NP	O
and	and	CC	I-NP	O
Hospital	Hospital	NN	I-NP	O
Course	Course	NN	I-NP	O
***	***	SYM	O	O
56yo	56yo	CD	B-NP	O
gentleman	gentleman	NN	I-NP	O
manifesting	manifest	VBG	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
non-medical	non-medical	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
CM	CM	NN	I-NP	O
***	***	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ischemia	ischemia	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
and	and	CC	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	O
as	as	IN	B-PP	O
manifest	manifest	NN	B-NP	O
by	by	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
RCA	RCA	NN	B-NP	B-protein
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
intervened	intervene	VBN	I-VP	O
upon	upon	IN	B-PP	O
in	in	IN	B-PP	O
19912/2	19912/2	CD	B-NP	O
collaterals	collateral	NNS	I-NP	O
and	and	CC	O	O
lesion	lesion	NN	B-VP	O
no	no	DT	B-NP	O
suspicious	suspicious	JJ	I-NP	O
for	for	IN	B-PP	O
pattern	pattern	NN	B-NP	O
of	of	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
here	here	RB	B-NP	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

Echo	Echo	NN	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
improved	improve	VBN	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
optimal	optimal	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
decrsd	decrsd	NN	I-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
59	59	CD	B-NP	O
%	%	NN	I-NP	O
1998	1998	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
ekg	ekg	NN	I-NP	O
changes	change	NNS	I-NP	O
c/w	c/w	VBP	B-VP	O
strain	strain	NN	B-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
mi	mi	NNS	B-NP	O
.	.	.	O	O

asa	asa	NN	B-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
acei	acei	NN	B-NP	O
.	.	.	O	O

Stress	Stress	NN	B-NP	O
mibi	mibi	NN	I-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
showed	show	VBD	B-VP	O
improved	improved	JJ	B-NP	O
ef	ef	NN	I-NP	O
to	to	TO	B-PP	O
38	38	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PDA/OM	PDA/OM	NN	I-NP	O
territory	territory	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
reversibility	reversibility	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
with	with	IN	B-PP	O
conservative	conservative	JJ	B-NP	O
medical	medical	JJ	I-NP	O
mngmnt	mngmnt	NN	I-NP	O
,	,	,	O	O
feel	feel	VBP	B-VP	O
confident	confident	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
pt	pt	NN	B-NP	O
.	.	.	O	O

does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
pci	pci	NNS	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

pump	pump	NN	B-NP	O
:	:	:	O	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
grossly	grossly	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
,	,	,	O	O
2/2	2/2	CD	B-NP	O
malignant	malignant	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	I-NP	O
chf	chf	NN	I-NP	O
.	.	.	O	O

echo	echo	NN	B-NP	O
showed	show	VBD	B-VP	O
ef	ef	NN	B-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
global	global	JJ	I-NP	B-protein
HK	HK	NN	I-NP	I-protein
.	.	.	O	O

aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
w/monitor	w/monitor	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
function/lytes	function/lyte	NNS	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
89kg	89kg	NN	B-NP	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
diuresed	diurese	VBN	I-VP	O
to	to	TO	B-PP	O
79kg	79kg	CD	B-NP	O
.	.	.	O	O

Improved	Improve	VBN	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
;	;	:	O	O
also	also	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
BNP	BNP	NN	B-NP	O
1374	1374	CD	I-NP	O
,	,	,	O	O
701	701	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Feel	Feel	NN	B-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
not	not	RB	O	O
his	his	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
60	60	CD	B-NP	O
lasix	lasix	CD	I-NP	O
QD	QD	NN	I-NP	B-protein
PO	PO	NN	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
htn	htn	NN	I-NP	O
responded	respond	VBD	B-VP	O
nicely	nicely	RB	B-ADVP	O
to	to	TO	B-PP	O
isordil	isordil	NN	B-NP	O
,	,	,	I-NP	O
hydral	hydral	NN	I-NP	O
,	,	,	I-NP	O
captopril	captopril	NN	I-NP	O
and	and	CC	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Once	Once	RB	O	O
past	past	IN	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
we	we	PRP	B-NP	O
restarted	restart	VBD	B-VP	O
beta	beta	SYM	B-NP	O
blockade	blockade	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
imdur	imdur	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-NP	O
g	g	NN	I-NP	O
o	o	NN	I-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
40QD	40QD	NN	I-NP	O
.	.	.	O	O

toprol	toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
150	150	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
imdur	imdur	IN	B-NP	O
120	120	CD	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

**	**	SYM	O	O
Endo	Endo	NNP	B-NP	O
:	:	:	O	O
h/o	h/o	NN	B-NP	O
Dm	Dm	NN	I-NP	O
with	with	IN	B-PP	O
complete	complete	JJ	B-NP	O
nonadherence	nonadherence	NN	I-NP	O
.	.	.	O	O

EDglucose	EDglucose	NN	B-NP	O
320	320	CD	I-NP	O
.	.	.	O	O

Started	Started	JJ	B-NP	O
lispro	lispro	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
started	start	VBD	I-VP	O
glipizide	glipizide	NN	B-NP	O
10	10	CD	I-NP	O
qAM	qAM	NN	I-NP	O
with	with	IN	B-PP	O
decent	decent	JJ	B-NP	O
con	con	NN	I-NP	O
trol	trol	NN	I-NP	O
.	.	.	O	O

HbA1c	HbA1c	NN	B-NP	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
11	11	CD	B-NP	O
.	.	.	O	O

AM	AM	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
and	and	CC	I-NP	O
TSH	TSH	NN	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
suggest	suggest	VB	I-VP	O
Cushing	Cushing	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
or	or	CC	O	O
thyroid	thyroid	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
wil	wil	VBP	B-VP	O
l	l	NN	B-NP	O
need	need	NN	I-NP	O
ophthalmology	ophthalmology	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
asap	asap	NN	B-NP	O
.	.	.	O	O

**	**	SYM	O	O
Renal	Renal	JJ	O	O
:	:	:	O	O
creatinine	creatinine	NN	B-NP	O
clearance	clearance	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
24	24	CD	B-NP	O
hour	hour	NN	I-NP	O
urine	urine	NN	I-NP	O
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
proteinuria	proteinuria	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cortisol	cortisol	NN	I-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
sti	sti	NNS	B-NP	O
ll	ll	VBP	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O
.	.	.	O	O

**	**	SYM	B-NP	O
Proph	Proph	NN	I-NP	O
:	:	:	O	O
colace	colace	NN	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
,	,	,	O	O
lovenox	lovenox	NN	B-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
Code	Code	NN	I-NP	O
:	:	:	O	O
full	full	JJ	B-NP	O
**	**	SYM	I-NP	O
Dispo	Dispo	NNP	I-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
for	for	IN	B-PP	O
medication	medication	NN	B-NP	O
teaching	teaching	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
BP	BP	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
.	.	.	O	O

Will	Will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
crestchild	crestchild	NN	B-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
center	center	NN	I-NP	O
home	home	NN	I-NP	O
chf	chf	NN	I-NP	O
program	program	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Clair	Clair	NNP	B-NP	O
K	K	NNP	I-NP	O
Dirth	Dirth	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
NP	NP	NNP	I-NP	O
at	at	IN	B-PP	O
TH	TH	NNP	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
pcp	pcp	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Jack	Jack	NNP	I-NP	O
Arena	Arena	NNP	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
not	not	RB	I-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
work	work	VB	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
learn	learn	VB	I-VP	O
his	his	PRP$	B-NP	O
new	new	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
adjust	adjust	VBP	B-VP	O
to	to	TO	B-PP	O
side	side	JJ	B-NP	O
effects	effect	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
lifestyle	lifestyle	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
vna	vna	NN	I-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
medication	medication	NN	B-NP	O
instruction	instruction	NN	I-NP	O
,	,	,	O	O
teaching	teach	VBG	B-VP	O
daily	daily	JJ	B-NP	O
weight	weight	NN	I-NP	O
technique	technique	NN	I-NP	O
,	,	,	O	O
monitor	monitor	NN	B-NP	O
BP	BP	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
draw	draw	NN	B-NP	O
chem7	chem7	NN	I-NP	O
on	on	IN	B-PP	O
friday	friday	NN	B-NP	O
and	and	CC	O	O
have	have	VB	B-VP	O
results	result	NNS	B-NP	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kurt	Kurt	NNP	I-NP	O
Chauhan	Chauhan	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GIANOPULOS	GIANOPULOS	NNP	B-NP	O
,	,	,	O	O
JACKIE	JACKIE	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR60	OR60	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/17/04	10/17/04	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
37	37	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

